Sol-Gel Technologies Ltd. · Drugmakers

SLGL

Moderate riskNext report: Not enough history

View price ↗

The short version

A company still losing money with growing sales. Institutions are adding.

Going well

Sales up 218% in the latest quarter vs a year ago
Sales up 68% last year
Buying back shares: share count down 3.6% in 3 years

Watch out for

Losing money, losses are large next to sales

Money moves

No insider buying or selling in the last 30 days
Institutions added 4.9% to their holdings in the quarter ending June 2026 (11 bought, 9 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$70.12+1.1% that day

Company value: $195M; Share price times all shares
Price vs profit (P/E): 25.2x; You pay about $25 for each $1 of yearly profit
Price vs sales: 7.3x; Company value is 7.3 times a year of sales
Cash vs value: 5%; Cash as a share of company value

From SLGL's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 8 quarters, from SEC filings

Sales, Jun '25

$17.3M

Jun '18Tap a barJun '25

Last 12 months: $26.8M, up 171% from the 12 months before. Over 5 years, sales grew about 17% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of SLGL. Starting points are the company's recent numbers.

Sales growth+17% a yearRecently: +17% a yearProfit margin28%Last 12 months: 27.9%P/E at the end25xToday: 25.2x. Many steady companies trade at 12x to 25xShare count change-1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$59M

Profit in 5 years$16M

Price these guesses point to$155.27+121% vs $70.12 todayAbout +17% a year, before dividends

What today's price needs: with a 28% margin and a 25x P/E, sales could shrink about 0.2% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/6Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-23.7%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-31.6%
MissProfitable every yearSteady profits, not one good year.1 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$275K
PassShare count not growingNot diluting owners. Falling means buybacks.-3.6% in 3 years

Revenue: $19.4M; +68.0% vs prior year
5-year growth: +17.2%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 4.37x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.